To attempt to contextualize this previous work with our current findings, we analyzed the effects of PBRM1 loss in four additional TCGA datasets with sufficient sample size (microsatellite stable endometrial cancer, microsatellite instable endometrial cancer, gastric cancer, and bladder cancer). The gene discussed is PBRM1; the disease is urinary bladder cancer.